These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
321 related articles for article (PubMed ID: 9573573)
21. [Hepatorenal syndrome]. Bosma JW; van Meyel JJ; Siegert CE Ned Tijdschr Geneeskd; 2010; 154():A1355. PubMed ID: 20456764 [No Abstract] [Full Text] [Related]
22. Pathogenetic factors and clinical elements in ascites and hepatorenal syndrome during liver cirrhosis. Gentilini P; Laffi G; La Villa G; Raggi VC Ann Ital Med Int; 1999; 14(4):264-84. PubMed ID: 10638019 [TBL] [Abstract][Full Text] [Related]
28. Type-2 hepatorenal syndrome and refractory ascites: role of transjugular intrahepatic portosystemic stent-shunt in eighteen patients with advanced cirrhosis awaiting orthotopic liver transplantation. Testino G; Ferro C; Sumberaz A; Messa P; Morelli N; Guadagni B; Ardizzone G; Valente U Hepatogastroenterology; 2003; 50(54):1753-5. PubMed ID: 14696397 [TBL] [Abstract][Full Text] [Related]
29. Current management and novel therapeutic strategies for refractory ascites and hepatorenal syndrome. Suzuki H; Stanley AJ QJM; 2001 Jun; 94(6):293-300. PubMed ID: 11391027 [TBL] [Abstract][Full Text] [Related]
32. Pathophysiology, clinical features and management of hepatorenal syndrome. Garzia P; Ferri GM; Ilardi M; Messina FR; Amoroso A Eur Rev Med Pharmacol Sci; 1998; 2(5-6):181-4. PubMed ID: 10710816 [TBL] [Abstract][Full Text] [Related]
33. Midodrine, octreotide, albumin, and TIPS in selected patients with cirrhosis and type 1 hepatorenal syndrome. Wong F; Pantea L; Sniderman K Hepatology; 2004 Jul; 40(1):55-64. PubMed ID: 15239086 [TBL] [Abstract][Full Text] [Related]
34. Management of ascites in patients with end-stage liver disease. Saadeh S; Davis GL Rev Gastroenterol Disord; 2004; 4(4):175-85. PubMed ID: 15580152 [TBL] [Abstract][Full Text] [Related]
35. [Treatment of hepatorenal syndrome]. Guevara M Gastroenterol Hepatol; 2003 Apr; 26(4):270-4. PubMed ID: 12681123 [No Abstract] [Full Text] [Related]
36. Pathophysiology and treatment of hepatorenal syndrome. Wong F; Blendis L Gastroenterologist; 1998 Jun; 6(2):122-35. PubMed ID: 9660529 [TBL] [Abstract][Full Text] [Related]
37. Fluid retention in cirrhosis: pathophysiology and management. Kashani A; Landaverde C; Medici V; Rossaro L QJM; 2008 Feb; 101(2):71-85. PubMed ID: 18184668 [TBL] [Abstract][Full Text] [Related]
38. The management of hepatorenal syndrome. Carl DE; Sanyal A Minerva Gastroenterol Dietol; 2009 Jun; 55(2):207-26. PubMed ID: 19305378 [TBL] [Abstract][Full Text] [Related]
39. [Hepatorenal syndrome: terminal stage of major complicances of hepatic cirrhosis]. Costantino S Clin Ter; 2004 Sep; 155(9):361-2. PubMed ID: 15700628 [No Abstract] [Full Text] [Related]
40. [Hepatorenal syndrome in patients with liver cirrhosis]. Zaza S; Bonny O; Liaudet L Nephrol Ther; 2005 Jul; 1(3):174-82. PubMed ID: 16895684 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]